'Major Advance' in Food Allergy Management: Experts Weigh in on OUtMATCH Data

(MedPage Today) -- At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers presented the phase III OUtMATCH study, which showed that omalizumab (Xolair) injections increased reaction thresholds for...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news